Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3Phase 1/2 1

Status

Recruiting 2Completed 2Withdrawn 1Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 8Lymphoid 1

Conditions

Carcinoma, Hepatocellular 37Liver Neoplasms 18Neoplasm Metastasis 17Colorectal Neoplasms 13Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 8Colonic Neoplasms 8Breast Neoplasms 8Barrett Esophagus 7Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 5Thyroid Nodule 4Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Biliary Tract Neoplasms 3Agnosia 3Thyroid Diseases 2Prostatic Neoplasms 2Leiomyoma 2Hyperaldosteronism 2Cancer Pain 2Bile Duct Neoplasms 2Uterine Cervical Neoplasms 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Radiofrequency Ablation × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

NCT01153035 2025-11-10

ABLATE

University of Arkansas

Phase NA Active not recruiting
104 enrolled
Breast

Breast Neoplasms

NCT04698252 2022-08-08

LARA

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
74 enrolled
Breast

Breast Neoplasms

NCT03750396 2019-02-15

CLEAR

Gangnam Severance Hospital

Phase 2 Unknown
110 enrolled
Breast

Breast Neoplasms

NCT02281812 2018-06-04

Radiofrequency Ablation in Breast Cancer

Hospital Universitari de Bellvitge

Phase NA Terminated
40 enrolled
Breast

Breast Neoplasms

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

University of Arkansas

Phase 1/2 Completed
32 enrolled
Breast

Breast Neoplasms

NCT00388115 2010-03-29

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

University of California, Davis

Phase NA Completed
15 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡